Periodontitis and Rheumatoid Arthritis: The Same Inflammatory Mediators?

Fulvia Ceccarelli, Matteo Saccucci, Gabriele Di Carlo, Ramona Lucchetti, Andrea Pilloni, Nicola Pranno, Valeria Luzzi, Guido Valesini, Antonella Polimeni, Fulvia Ceccarelli, Matteo Saccucci, Gabriele Di Carlo, Ramona Lucchetti, Andrea Pilloni, Nicola Pranno, Valeria Luzzi, Guido Valesini, Antonella Polimeni

Abstract

The strict link between periodontitis (PD) and rheumatoid arthritis (RA) has been widely demonstrated by several studies. PD is significantly more frequent in RA patients in comparison with healthy subjects: this prevalence is higher in individuals at the earliest stages of disease and in seropositive patients. This is probably related to the role of P. gingivalis in inducing citrullination and leading to the development of the new antigens. Despite the many studies conducted on this topic, there is very little data available concerning the possibility to use the same biomarkers to evaluate both RA and PD patients. The aim of the review is to summarize this issue. Starting from genetic factors, data from literature demonstrated the association between HLA-DRB1 alleles and PD susceptibility, similar to RA patients; moreover, SE-positive patients showed simultaneously structural damage to the wrist and periodontal sites. Contrasting results are available concerning other genetic polymorphisms. Moreover, the possible role of proinflammatory cytokines, such as TNF and IL6 and autoantibodies, specifically anticyclic citrullinated peptide antibodies, has been examined, suggesting the need to perform further studies to better define this issue.

Figures

Figure 1
Figure 1
Suggested genetic factors, inflammatory biomarkers, and autoantibodies shared by rheumatoid arthritis and periodontitis. IL1: interleukin-1; TNF: tumor necrosis factor; MMP1: matrix metalloproteinase-1; MMP8: matrix metalloproteinase-8; ACPA: anticyclic citrullinated peptide antibodies.

References

    1. Potempa J., Mydel P., Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nature Reviews Rheumatology. 2017;13(10):606–620. doi: 10.1038/nrrheum.2017.132.
    1. Bartold P. M., Marshall R. I., Haynes D. R. Periodontitis and rheumatoid arthritis: a review. Journal of Periodontology. 2005;76(11-s):2066–2074. doi: 10.1902/jop.2005.76.11-S.2066.
    1. De Pablo P., Chapple I. L., Buckley C. D., Dietrich T. Periodontitis in systemic rheumatic diseases. Nature Reviews Rheumatology. 2009;5(4):218–224. doi: 10.1038/nrrheum.2009.28.
    1. Diaz P. I., Hoare A., Hong B. Y. Subgingival microbiome shifts and community dynamics in periodontal diseases. Journal of the California Dental Association. 2016;44(7):421–435.
    1. Lamont R. J., Hajishengallis G. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends in Molecular Medicine. 2015;21(3):172–183. doi: 10.1016/j.molmed.2014.11.004.
    1. Abusleme L., Dupuy A. K., Dutzan N., et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. The ISME Journal. 2013;7(5):1016–1025. doi: 10.1038/ismej.2012.174.
    1. Harvey G. P., Fitzsimmons T. R., Dhamarpatni A. A., Marchant C., Haynes D., Bartold P. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. Journal of Periodontal Research. 2013;48(2):252–261. doi: 10.1111/jre.12002.
    1. Valesini G., Gerardi M. C., Iannuccelli C., Pacucci V. A., Pendolino M., Shoenfeld Y. Citrullination and autoimmunity. Autoimmunity Reviews. 2015;14(6):490–497. doi: 10.1016/j.autrev.2015.01.013.
    1. Ceccarelli F., Orrù G., Pilloni A., et al. Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients. Clinical and Experimental Immunology. 2018;194(2):244–252. doi: 10.1111/cei.13184.
    1. Saccucci M., Di Carlo G., Bossù M., Giovarruscio F., Salucci A., Polimeni A. Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management. Journal of Immunology Research. 2018;2018:6. doi: 10.1155/2018/6061825.6061825
    1. Konig M. F., Abusleme L., Reinholdt J., et al. Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Science Translational Medicine. 2016;8(369, article 369ra176) doi: 10.1126/scitranslmed.aaj1921.
    1. Pischon N., Pischon T., Kröger J., et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. Journal of Periodontology. 2008;79(6):979–986. doi: 10.1902/jop.2008.070501.
    1. Dissick A., Redman R. S., Jones M., et al. Association of periodontitis with rheumatoid arthritis: a pilot study. Journal of Periodontology. 2010;81(2):223–230. doi: 10.1902/jop.2009.090309.
    1. Scher J. U., Ubeda C., Equinda M., et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis & Rheumatism. 2012;64(10):3083–3094. doi: 10.1002/art.34539.
    1. de Smit M., Westra J., Vissink A., der Meer B. D.-v., Brouwer E., van Winkelhoff A. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Research & Therapy. 2012;14(5, article R222) doi: 10.1186/ar4061.
    1. Ranade S. B., Doiphode S. Is there a relationship between periodontitis and rheumatoid arthritis? Journal of Indian Society of Periodontology. 2012;16(1):22–27. doi: 10.4103/0972-124X.94599.
    1. Reichert S., Haffner M., Keyßer G., et al. Detection of oral bacterial DNA in synovial fluid. Journal of Clinical Periodontology. 2013;40(6):591–598. doi: 10.1111/jcpe.12102.
    1. Wolff B., Berger T., Frese C., et al. Oral status in patients with early rheumatoid arthritis: a prospective, case-control study. Rheumatology. 2014;53(3):526–531. doi: 10.1093/rheumatology/ket362.
    1. Joseph R., Rajappan S., Nath S. G., Paul B. J. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case-control study. Rheumatology International. 2013;33(1):103–109. doi: 10.1007/s00296-011-2284-1.
    1. Chen H. H., Chen D. Y., Lai K. L., et al. Periodontitis and etanercept discontinuation risk in anti–tumor necrosis factor–naive rheumatoid arthritis patients: a nationwide population-based cohort study. Journal of Clinical Rheumatology. 2013;19(8):432–438. doi: 10.1097/RHU.0000000000000041.
    1. Eriksson K., Nise L., Kats A., et al. Prevalence of periodontitis in patients with established rheumatoid arthritis: a Swedish population based case-control study. PLoS One. 2016;11(5, article e0155956) doi: 10.1371/journal.pone.0155956.
    1. Potikuri D., Dannana K. C., Kanchinadam S., et al. Periodontal disease is significantly higher in non-smoking treatment-naive rheumatoid arthritis patients: results from a case-control study. Annals of the Rheumatic Diseases. 2012;71(9):1541–1544. doi: 10.1136/annrheumdis-2011-200380.
    1. Choi I. A., Kim J. H., Kim Y. M., et al. Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea. The Korean Journal of Internal Medicine. 2016;31(5):977–986. doi: 10.3904/kjim.2015.202.
    1. Äyräväinen L., Leirisalo-Repo M., Kuuliala A., et al. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population. BMJ Open. 2017;7(1, article e011916) doi: 10.1136/bmjopen-2016-011916.
    1. Gonzalez S. M., Payne J. B., Yu F., et al. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. Journal of Periodontology. 2015;86(2):222–231. doi: 10.1902/jop.2014.140425.
    1. Mikuls T. R., Payne J. B., Yu F., et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis & Rhematology. 2014;66(5):1090–1100. doi: 10.1002/art.38348.
    1. Perricone C., Ceccarelli F., Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmunity Reviews. 2011;10(10):599–608. doi: 10.1016/j.autrev.2011.04.021.
    1. Genevay S., Di Giovine F. S., Perneger T. V., et al. Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis & Rheumatism. 2002;47(3):303–309. doi: 10.1002/art.10394.
    1. Mewar D., Marinou I., Coote A. L., et al. Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection. Annals of the Rheumatic Diseases. 2008;67(7):980–983. doi: 10.1136/ard.2007.075382.
    1. Fonseca J. E., Cavaleiro J., Teles J., et al. Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Research & Therapy. 2007;9(2, article R37) doi: 10.1186/ar2173.
    1. Ceccarelli F., Perricone C., Fabris M., et al. Transforming growth factor β 869C/T and interleukin 6 -174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Research & Therapy. 2011;13(4, article R111) doi: 10.1186/ar3396.
    1. Marotte H., Farge P., Gaudin P., Alexandre C., Mougin B., Miossec P. The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction. Annals of the Rheumatic Diseases. 2006;65(7):905–909. doi: 10.1136/ard.2005.036913.
    1. Bonfil J. J., Dillier F. L., Mercier P., et al. A “case control” study on the rôle of HLA DR4 in severe periodontitis and rapidly progressive periodontitis: identification of types and subtypes using molecular biology (PCR.SSO) Journal of Clinical Periodontology. 1999;26(2):77–84. doi: 10.1034/j.1600-051X.1999.260203.x.
    1. Gehlot P., Volk S. L., Rios H. F., Jepsen K. J., Holoshitz J. Spontaneous destructive periodontitis and skeletal bone damage in transgenic mice carrying a human shared epitope-coding HLA-DRB1 allele. RMD Open. 2016;2(2, article e000349) doi: 10.1136/rmdopen-2016-000349.
    1. Laine M. L., Crielaard W., Loos B. G. Genetic susceptibility to periodontitis. Periodontology 2000. 2012;58:37–68. doi: 10.1111/j.1600-0757.2011.00415.x.
    1. Nikolopoulos G. K., Dimou N. L., Hamodrakas S. J., Bagos P. G. Cytokine gene polymorphisms in periodontal disease: a meta-analysis of 53 studies including 4178 cases and 4590 controls. Journal of Clinical Periodontology. 2008;35(9):754–767. doi: 10.1111/j.1600-051X.2008.01298.x.
    1. Kobayashi T., Kido J. I., Ishihara Y., et al. The KCNQ1 gene polymorphism as a shared genetic risk for rheumatoid arthritis and chronic periodontitis in Japanese adults: a pilot case-control study. Journal of Periodontology. 2018;89(3):315–324. doi: 10.1002/JPER.17-0412.
    1. Hu X., Laragione T., Sun L., et al. KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis. Journal of Biological Chemistry. 2012;287(6):4014–4022. doi: 10.1074/jbc.M111.312264.
    1. Kobayashi T., Yoshie H. Host responses in the link between periodontitis and rheumatoid arthritis. Current Oral Health Reports. 2015;2(1):1–8. doi: 10.1007/s40496-014-0039-2.
    1. Liu C. M., Hou L. T., Wong M. Y., Rossomando E. F. Relationships between clinical parameters, interleukin 1B and histopathologic findings of gingival tissue in periodontitis patients. Cytokine. 1996;8(2):161–167. doi: 10.1006/cyto.1996.0023.
    1. Conti F., Ceccarelli F., Massaro L., et al. Biological therapies in rheumatic diseases. La Clinica Terapeutica. 2013;164(5):e413–e428. doi: 10.7417/CT.2013.1622.
    1. Ataoğlu T., Ungör M., Serpek B., Haliloglu S., Ataoglu H., Ari H. Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates. International Endodontic Journal. 2002;35(2):181–185. doi: 10.1046/j.1365-2591.2002.00467.x.
    1. Delima A. J., Oates T., Assuma R., et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. Journal of Clinical Periodontology. 2001;28(3):233–240. doi: 10.1034/j.1600-051x.2001.028003233.x.
    1. Cetinkaya B., Guzeldemir E., Ogus E., Bulut S. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis. Journal of Periodontology. 2013;84(1):84–93. doi: 10.1902/jop.2012.110467.
    1. Mirrielees J., Crofford L. J., Lin Y., et al. Rheumatoid arthritis and salivary biomarkers of periodontal disease. Journal of Clinical Periodontology. 2010;37(12):1068–1074. doi: 10.1111/j.1600-051X.2010.01625.x.
    1. Kobayashi T., Ito S., Kobayashi D., et al. Serum immunoglobulin G levels to Porphyromonas gingivalis peptidylarginine deiminase affect clinical response to biological disease-modifying antirheumatic drug in rheumatoid arthritis. PLoS One. 2016;11(4, article e0154182) doi: 10.1371/journal.pone.0154182.
    1. Jung G. U., Han J. Y., Hwang K. G., Park C. J., Stathopoulou P. G., Fiorellini J. P. Effects of conventional synthetic disease-modifying antirheumatic drugs on response to periodontal treatment in patients with rheumatoid arthritis. BioMed Research International. 2018;2018:7. doi: 10.1155/2018/1465402.1465402
    1. Zhao X., Liu Z., Shu D., et al. Association of periodontitis with rheumatoid arthritis and the effect of non-surgical periodontal treatment on disease activity in patients with rheumatoid arthritis. Medical Science Monitor. 2018;24:5802–5810. doi: 10.12659/MSM.909117.
    1. Wegner N., Lundberg K., Kinloch A., et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunological Reviews. 2010;233(1):34–54. doi: 10.1111/j.0105-2896.2009.00850.x.
    1. De Pablo P., Dietrich T., Chapple I. L. C., et al. The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis? Annals of the Rheumatic Diseases. 2014;73(3):580–586. doi: 10.1136/annrheumdis-2012-202701.
    1. Gonzales J. R. T- and B-cell subsets in periodontitis. Periodontology 2000. 2015;69(1):181–200. doi: 10.1111/prd.12090.
    1. Janssen K. M. J., de Smit M. J., Withaar C., et al. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients. Journal of Clinical Periodontology. 2017;44(6):577–584. doi: 10.1111/jcpe.12727.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner